↓ Skip to main content

Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential

Overview of attention for article published in Marine Drugs, April 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#40 of 3,974)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
5 news outlets
twitter
27 X users
patent
1 patent
facebook
8 Facebook pages
wikipedia
3 Wikipedia pages
googleplus
2 Google+ users
video
1 YouTube creator

Citations

dimensions_citation
257 Dimensions

Readers on

mendeley
352 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential
Published in
Marine Drugs, April 2015
DOI 10.3390/md13042327
Pubmed ID
Authors

Farzaneh Atashrazm, Ray M. Lowenthal, Gregory M. Woods, Adele F. Holloway, Joanne L. Dickinson

Abstract

There is a wide variety of cancer types yet, all share some common cellular and molecular behaviors. Most of the chemotherapeutic agents used in cancer treatment are designed to target common deregulated mechanisms within cancer cells. Many healthy tissues are also affected by the cytotoxic effects of these chemical agents. Fucoidan, a natural component of brown seaweed, has anti-cancer activity against various cancer types by targeting key apoptotic molecules. It also has beneficial effects as it can protect against toxicity associated with chemotherapeutic agents and radiation. Thus the synergistic effect of fucoidan with current anti-cancer agents is of considerable interest. This review discusses the mechanisms by which fucoidan retards tumor development, eradicates tumor cells and synergizes with anti-cancer chemotherapeutic agents. Challenges to the development of fucoidan as an anti-cancer agent will also be discussed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 352 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 <1%
Unknown 351 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 55 16%
Student > Master 48 14%
Researcher 39 11%
Student > Ph. D. Student 36 10%
Other 12 3%
Other 48 14%
Unknown 114 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 56 16%
Agricultural and Biological Sciences 51 14%
Pharmacology, Toxicology and Pharmaceutical Science 22 6%
Chemistry 21 6%
Medicine and Dentistry 13 4%
Other 55 16%
Unknown 134 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 67. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#647,341
of 25,736,439 outputs
Outputs from Marine Drugs
#40
of 3,974 outputs
Outputs of similar age
#7,571
of 280,028 outputs
Outputs of similar age from Marine Drugs
#2
of 74 outputs
Altmetric has tracked 25,736,439 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,974 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,028 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.